Treatment of Growth Hormone Deficiency via Daily Intravascular Injections in a Child with Bleeding Disorder

Table 1

Laboratory results of selected biomarkers of the patient before and after growth hormone treatment.

Age (years, months)	2^5/12 years (before rhGH)	3^2/12 years (before rhGH)	5^2/12 years (5 months after rhGH)	6^1/12 years (16 months after rhGH)
IGF1 concentration (ng/mL)	<15	<15	29	41
IGF1 SDS score			−2.33	−2.17
IGFBP3 concentration (mg/L, RR: 0.8–3.9)	0.65	0.8	1.6
TSH (mIU/L)	2.1		2.6	1.3
Free T4 (ng/dL)	1.1		0.9	0.9
Albumin (gr/dL)			4.3
ALT (IU/L)			27
AST (IU/L)			20
HbA1c (%)			4.7	4.5
Protein C functional (%, RR: 40–92)	14	14	11	12